HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gerald A Fishman Selected Research

Retinoschisis (Retinoschisis, Juvenile)

1/2022Contrast Sensitivity and Equivalent Intrinsic Noise in X-Linked Retinoschisis.
10/2021Luminance Thresholds and Their Correlation With Retinal Structure in X-Linked Retinoschisis.
11/2018STRUCTURAL AND FUNCTIONAL MONITORING OF EXTRAMACULAR CYSTOID SPACES IN A CASE OF X-LINKED RETINOSCHISIS TREATED WITH ACETAZOLAMIDE.
8/2017USE OF A CARBONIC ANHYDRASE INHIBITOR IN X-LINKED RETINOSCHISIS: Effect on Cystic-Appearing Macular Lesions and Visual Acuity.
6/2014Resolution of mid-peripheral schisis in x-linked retinoschisis with the use of dorzolamide.
2/2011The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis.
2/2010Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis.
1/2009Relation of response to treatment with dorzolamide in X-linked retinoschisis to the mechanism of functional loss in retinoschisin.
4/2008Detection of mosaic retinal dysfunction in choroideremia carriers electroretinographic and psychophysical testing.
1/2007Multifocal ERG findings in carriers of X-linked retinoschisis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gerald A Fishman Research Topics

Disease

18Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2015 - 03/2002
11Retinoschisis (Retinoschisis, Juvenile)
01/2022 - 09/2006
9Stargardt Disease
01/2016 - 07/2004
8Macular Edema
10/2020 - 05/2006
5Cysts
08/2017 - 01/2009
4Enhanced S-Cone Syndrome
01/2016 - 01/2009
4Retinal Diseases
10/2013 - 06/2002
4Choroideremia
04/2012 - 04/2008
3Cataract (Cataracts)
01/2009 - 01/2002
2Ocular Paraneoplastic Syndromes
10/2016 - 03/2011
2Macular Degeneration (Age-Related Maculopathy)
01/2015 - 11/2014
2Cone-Rod Dystrophies
12/2012 - 08/2009
2Diabetic Retinopathy (Retinopathy, Diabetic)
10/2011 - 09/2010
2Bardet-Biedl Syndrome (Syndrome, Bardet-Biedl)
07/2010 - 09/2007
2Leber Congenital Amaurosis
09/2008 - 09/2006
2Cone Dystrophy
06/2005 - 01/2005
1Corneal Opacity
12/2020
1Autoimmune Diseases (Autoimmune Disease)
10/2016
1Cicatrix (Scar)
10/2016
1Melanoma (Melanoma, Malignant)
10/2016
1Hypersensitivity (Allergy)
01/2016
1North Carolina type 1 retinal Macular dystrophy
01/2016
1Optic Atrophy
01/2015
1Homocystinuria
01/2015
1Methylmalonic acidemia
01/2015
1Rare Diseases (Rare Disease)
11/2014
1Atrophy
07/2014
1Retinal Degeneration
12/2012
1congenital stationary Night blindness
12/2012
1Ganglion Cysts (Ganglion)
12/2012
1Oguchi disease
12/2012
1Wallerian Degeneration
09/2012
1Hemoglobinopathies
10/2011
1Hereditary Sensory and Motor Neuropathy (Dejerine Sottas Disease)
09/2011
1Hereditary Motor And Sensory Neuropathy VI
09/2011
1beta-Thalassemia (Cooley's Anemia)
10/2010
1Usher Syndromes (Usher Syndrome)
09/2010
1Vitamin A Deficiency
12/2009
1Keratoconus
07/2009
1Blindness (Hysterical Blindness)
09/2008
1Night Blindness (Nyctalopia)
03/2005
1Fundus Albipunctatus
01/2004
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
06/2003
1Central Serous Chorioretinopathy
07/2002

Drug/Important Bio-Agent (IBA)

40Retinaldehyde (Retinal)IBA
01/2022 - 03/2002
10dorzolamide (Trusopt)FDA LinkGeneric
06/2014 - 05/2006
9Carbonic Anhydrase InhibitorsIBA
10/2020 - 09/2006
3Acetazolamide (Diamox)FDA LinkGeneric
11/2018 - 05/2006
3Proteins (Proteins, Gene)FDA Link
01/2015 - 01/2009
3DNA (Deoxyribonucleic Acid)IBA
10/2013 - 06/2002
3Rhodopsin (Visual Purple)IBA
02/2013 - 08/2003
3Ophthalmic Solutions (Eye Drops)IBA
12/2010 - 01/2009
2Retinal Pigments (Pigments, Visual)IBA
01/2015 - 07/2014
2Cone OpsinsIBA
12/2009 - 06/2005
1mirdametinibIBA
12/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2020
1pembrolizumabIBA
10/2016
1Immune Checkpoint InhibitorsIBA
10/2016
1Transcription Factors (Transcription Factor)IBA
01/2016
1Deoxyribonucleases (DNase)FDA Link
01/2016
1lecithin-retinol acyltransferaseIBA
01/2015
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
01/2015
1retinol acetateIBA
01/2015
1Glycoproteins (Glycoprotein)IBA
11/2014
1Fibrillin-2IBA
11/2014
1ElastinIBA
11/2014
1CationsIBA
03/2011
1AutoantibodiesIBA
03/2011
1Deferoxamine (Desferal)FDA LinkGeneric
10/2010
1Fluorescein (Funduscein)FDA LinkGeneric
10/2010
1ChaperoninsIBA
07/2010
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2009
1RetinoidsIBA
09/2008
1GTP Phosphohydrolases (GTPases)IBA
03/2008
1MethazolamideFDA LinkGeneric
05/2006
1OpsinsIBA
06/2005
1metabotropic glutamate receptor 6IBA
03/2005
1NucleotidesIBA
01/2005
15' Untranslated Regions (5' UTR)IBA
01/2005
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2005
1Messenger RNA (mRNA)IBA
01/2005
1Carrier Proteins (Binding Protein)IBA
01/2004
1Codon (Codons)IBA
08/2003
1Pharmaceutical PreparationsIBA
06/2003

Therapy/Procedure

5Lasers (Laser)
07/2014 - 12/2010
3Slit Lamp
02/2012 - 01/2002
2Therapeutics
09/2010 - 02/2010
1Retreatment
02/2011
1Blood Transfusion (Blood Transfusions)
10/2010
1Duration of Therapy
09/2010
1Gastric Bypass (Roux-en-Y Gastric Bypass)
12/2009